Moss Adams Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Buy
7,424
+427
+6% +$91.9K 0.12% 61
2026
Q1
$1.52M Buy
6,997
+562
+9% +$125K 0.11% 59
2025
Q4
$1.47M Buy
6,435
+175
+3% +$39.9K 0.11% 59
2025
Q3
$1.45M Sell
6,260
-350
-5% -$71.3K 0.11% 57
2025
Q2
$1.23M Buy
6,610
+373
+6% +$69.3K 0.11% 64
2025
Q1
$1.31M Buy
6,237
+1,531
+33% +$298K 0.14% 52
2024
Q4
$836K Buy
4,706
+203
+5% +$37.3K 0.09% 72
2024
Q3
$889K Buy
4,503
+588
+15% +$110K 0.1% 65
2024
Q2
$672K Buy
3,915
+723
+23% +$120K 0.09% 65
2024
Q1
$581K Buy
3,192
+1,139
+55% +$196K 0.09% 69
2023
Q4
$318K Sell
2,053
-228
-10% -$33.2K 0.07% 77
2023
Q3
$340K Buy
+2,281
New +$335K 0.12% 60

Other funds holding ABBV

Moss Adams Wealth Advisors's ABBV Position: Q2 2026 in Review

Moss Adams Wealth Advisors increased its AbbVie (ABBV) stake by 6.1% in Q2 2026, buying an estimated $91.9K and bringing the position to 7,424 shares worth $1.87M. The position accounts for 0.12% of the portfolio, ranked #61.

Moss Adams Wealth Advisors first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Moss Adams Wealth Advisors held 7,424 shares of AbbVie worth $1.87M as of Q2 2026.
  • Moss Adams Wealth Advisors bought 427 AbbVie shares in Q2 2026, an estimated $91.9K.
  • AbbVie made up 0.12% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #61 holding.
  • Moss Adams Wealth Advisors first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.